0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Sjögren's Syndrome in Progressive Systemic Sclerosis

JAMES F. CIPOLETTI, M.D.; ROBERT B. BUCKINGHAM, M.D., F.A.C.P.; E. LEON BARNES, M.D.; ROBERT L. PEEL, M.D.; KHALID MAHMOOD, M.D.; FRANKLIN E. CIGNETTI, M.D.; JOHN M. PIERCE, M.D.; BRUCE S. RABIN, M.D.; and GERALD P. RODNAN, M.D., F.A.C.P.
[+] Article and Author Information

Presented in part at the Southeastern Regional Meeting of the American-Rheumatism Association, San Juan, Puerto Rico, December 1975.

▸Requests for reprints should be addressed to Robert B. Buckingham, M.D.; Department of Medicine, University of Pittsburgh; Pittsburgh, PA 15261.


Pittsburgh, Pennsylvania


Ann Intern Med. 1977;87(5):535-541. doi:10.7326/0003-4819-87-5-535
Text Size: A A A

Thirty-five consecutive patients with progressive systemic sclerosis were prospectively evaluated for evidence of Sjögren's syndrome. Six of the 35 (17%) were judged to have the disorder. This is a higher prevalence than in most reports, but much lower than that recently reported by Alarcón-Segovia and associates (7). An additional 17 of the 35 patients (48%) had significant fibrosis in the absence of sufficient mononuclear cell infiltrates to confirm the diagnosis of Sjögren's syndrome. This group had particularly aggressive scleroderma with serious visceral features, and five died after a short duration of illness. No significant abnormalities were found in biopsies from six patients with the mixed connective tissue disease syndrome, five with Raynaud's phenomenon alone, or in 29 autopsy control subjects who had no evidence of connective tissue disease. Fibrosis in the absence of mononuclear infiltration in minor salivary glands of patients with progressive systemic sclerosis indicates a poor prognosis.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Hair disorders associated with autoimmune connective tissue diseases. G Ital Dermatol Venereol Published online Jun 30, 2014.;
Type I interferon in human autoimmunity. Front Immunol 2014;5():306.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)